vs
Side-by-side financial comparison of GE HealthCare (GEHC) and Kyndryl Holdings, Inc. (KD). Click either name above to swap in a different company.
GE HealthCare is the larger business by last-quarter revenue ($5.1B vs $3.9B, roughly 1.3× Kyndryl Holdings, Inc.). GE HealthCare runs the higher net margin — 8.0% vs 1.5%, a 6.5% gap on every dollar of revenue. On growth, GE HealthCare posted the faster year-over-year revenue change (7.4% vs 3.1%). Kyndryl Holdings, Inc. produced more free cash flow last quarter ($208.0M vs $112.0M). Over the past eight quarters, GE HealthCare's revenue compounded faster (3.0% CAGR vs 0.1%).
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
Kyndryl Holdings, Inc. is an American multinational information technology infrastructure services provider, headquartered in New York City and created from the spin-off of IBM's infrastructure services business in 2021. The company designs, builds, manages and develops large-scale information systems. The company also has business advisory services. It is currently the world's largest IT infrastructure services provider, and the fifth-largest consulting provider.
GEHC vs KD — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $5.1B | $3.9B |
| Net Profit | $411.0M | $57.0M |
| Gross Margin | 38.5% | 21.8% |
| Operating Margin | 10.0% | 2.4% |
| Net Margin | 8.0% | 1.5% |
| Revenue YoY | 7.4% | 3.1% |
| Net Profit YoY | -30.1% | -73.5% |
| EPS (diluted) | $0.85 | $0.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $5.1B | — | ||
| Q4 25 | $5.7B | $3.9B | ||
| Q3 25 | $5.1B | $3.7B | ||
| Q2 25 | $5.0B | $3.7B | ||
| Q1 25 | $4.8B | $3.8B | ||
| Q4 24 | $5.3B | $3.7B | ||
| Q3 24 | $4.9B | $3.8B | ||
| Q2 24 | $4.8B | $3.7B |
| Q1 26 | $411.0M | — | ||
| Q4 25 | $588.0M | $57.0M | ||
| Q3 25 | $446.0M | $68.0M | ||
| Q2 25 | $486.0M | $56.0M | ||
| Q1 25 | $564.0M | $69.0M | ||
| Q4 24 | $721.0M | $215.0M | ||
| Q3 24 | $470.0M | $-43.0M | ||
| Q2 24 | $428.0M | $11.0M |
| Q1 26 | 38.5% | — | ||
| Q4 25 | 39.7% | 21.8% | ||
| Q3 25 | 38.7% | 21.5% | ||
| Q2 25 | 39.6% | 21.3% | ||
| Q1 25 | 42.1% | 21.7% | ||
| Q4 24 | 42.8% | 20.4% | ||
| Q3 24 | 41.7% | 19.9% | ||
| Q2 24 | 41.4% | 21.5% |
| Q1 26 | 10.0% | — | ||
| Q4 25 | 14.5% | 2.4% | ||
| Q3 25 | 12.7% | 2.6% | ||
| Q2 25 | 13.1% | 2.5% | ||
| Q1 25 | 13.2% | 3.1% | ||
| Q4 24 | 15.1% | 6.9% | ||
| Q3 24 | 13.9% | -0.1% | ||
| Q2 24 | 12.6% | 1.7% |
| Q1 26 | 8.0% | — | ||
| Q4 25 | 10.3% | 1.5% | ||
| Q3 25 | 8.7% | 1.8% | ||
| Q2 25 | 9.7% | 1.5% | ||
| Q1 25 | 11.8% | 1.8% | ||
| Q4 24 | 13.6% | 5.7% | ||
| Q3 24 | 9.7% | -1.1% | ||
| Q2 24 | 8.8% | 0.3% |
| Q1 26 | $0.85 | — | ||
| Q4 25 | $1.28 | $0.25 | ||
| Q3 25 | $0.98 | $0.29 | ||
| Q2 25 | $1.06 | $0.23 | ||
| Q1 25 | $1.23 | $0.30 | ||
| Q4 24 | $1.58 | $0.89 | ||
| Q3 24 | $1.02 | $-0.19 | ||
| Q2 24 | $0.93 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.3B |
| Total DebtLower is stronger | $10.1B | $2.3B |
| Stockholders' EquityBook value | $10.7B | $1.2B |
| Total Assets | $37.1B | $11.3B |
| Debt / EquityLower = less leverage | 0.95× | 1.92× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.5B | $1.3B | ||
| Q3 25 | $4.0B | $1.3B | ||
| Q2 25 | $3.7B | $1.5B | ||
| Q1 25 | $2.5B | $1.8B | ||
| Q4 24 | $2.9B | $1.5B | ||
| Q3 24 | $3.5B | $1.3B | ||
| Q2 24 | $2.0B | $1.3B |
| Q1 26 | $10.1B | — | ||
| Q4 25 | $10.0B | $2.3B | ||
| Q3 25 | $10.3B | $3.0B | ||
| Q2 25 | $10.3B | $3.0B | ||
| Q1 25 | $8.8B | $3.0B | ||
| Q4 24 | $9.0B | $3.1B | ||
| Q3 24 | $10.3B | $3.1B | ||
| Q2 24 | $9.2B | $3.1B |
| Q1 26 | $10.7B | — | ||
| Q4 25 | $10.4B | $1.2B | ||
| Q3 25 | $10.0B | $1.2B | ||
| Q2 25 | $9.7B | $1.2B | ||
| Q1 25 | $9.2B | $1.2B | ||
| Q4 24 | $8.4B | $1.1B | ||
| Q3 24 | $8.3B | $1.1B | ||
| Q2 24 | $7.8B | $996.0M |
| Q1 26 | $37.1B | — | ||
| Q4 25 | $36.9B | $11.3B | ||
| Q3 25 | $36.1B | $11.2B | ||
| Q2 25 | $35.5B | $11.5B | ||
| Q1 25 | $33.6B | $10.5B | ||
| Q4 24 | $33.1B | $9.9B | ||
| Q3 24 | $33.9B | $10.4B | ||
| Q2 24 | $31.9B | $10.2B |
| Q1 26 | 0.95× | — | ||
| Q4 25 | 0.96× | 1.92× | ||
| Q3 25 | 1.03× | 2.45× | ||
| Q2 25 | 1.06× | 2.44× | ||
| Q1 25 | 0.95× | 2.50× | ||
| Q4 24 | 1.06× | 2.81× | ||
| Q3 24 | 1.24× | 2.92× | ||
| Q2 24 | 1.18× | 3.12× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $428.0M |
| Free Cash FlowOCF − Capex | $112.0M | $208.0M |
| FCF MarginFCF / Revenue | 2.2% | 5.4% |
| Capex IntensityCapex / Revenue | — | 5.7% |
| Cash ConversionOCF / Net Profit | — | 7.51× |
| TTM Free Cash FlowTrailing 4 quarters | — | $299.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $428.0M | ||
| Q3 25 | — | $146.0M | ||
| Q2 25 | $94.0M | $-124.0M | ||
| Q1 25 | $250.0M | $581.0M | ||
| Q4 24 | — | $260.0M | ||
| Q3 24 | — | $149.0M | ||
| Q2 24 | $-119.0M | $-48.0M |
| Q1 26 | $112.0M | — | ||
| Q4 25 | — | $208.0M | ||
| Q3 25 | — | $17.0M | ||
| Q2 25 | $8.0M | $-267.0M | ||
| Q1 25 | $98.0M | $341.0M | ||
| Q4 24 | — | $151.0M | ||
| Q3 24 | — | $15.0M | ||
| Q2 24 | $-183.0M | $-170.0M |
| Q1 26 | 2.2% | — | ||
| Q4 25 | — | 5.4% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | 0.2% | -7.1% | ||
| Q1 25 | 2.1% | 9.0% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | -3.8% | -4.5% |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 5.7% | ||
| Q3 25 | 2.1% | 3.5% | ||
| Q2 25 | 1.7% | 3.8% | ||
| Q1 25 | 3.2% | 6.3% | ||
| Q4 24 | 1.9% | 2.9% | ||
| Q3 24 | 1.9% | 3.6% | ||
| Q2 24 | 1.3% | 3.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 7.51× | ||
| Q3 25 | — | 2.15× | ||
| Q2 25 | 0.19× | -2.21× | ||
| Q1 25 | 0.44× | 8.42× | ||
| Q4 24 | — | 1.21× | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.28× | -4.36× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GEHC
| Imaging revenues | $2.3B | 45% |
| AVS revenues | $1.3B | 26% |
| PDx revenues | $770.0M | 15% |
| PCS revenues | $704.0M | 14% |
| Other revenues | $18.0M | 0% |
KD
| Principal Markets Segment | $1.4B | 37% |
| United States Segment | $958.0M | 25% |
| Strategic Markets Segment | $905.0M | 23% |
| Other | $568.0M | 15% |
